(19)
(11) EP 3 313 371 A2

(12)

(88) Date of publication A3:
16.03.2017

(43) Date of publication:
02.05.2018 Bulletin 2018/18

(21) Application number: 16738302.5

(22) Date of filing: 24.06.2016
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 35/745(2015.01)
A23L 33/135(2016.01)
A61K 35/744(2015.01)
A61K 35/747(2015.01)
(86) International application number:
PCT/US2016/039444
(87) International publication number:
WO 2016/210384 (29.12.2016 Gazette 2016/52)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 25.06.2015 US 201562184777 P
11.01.2016 US 201662277346 P
10.02.2016 US 201662293695 P
13.05.2016 US 201662336012 P
13.05.2016 WO PCT/US2016/032565
08.06.2016 US 201662347576 P
08.06.2016 US 201662347554 P
08.06.2016 US 201662347508 P
10.06.2016 US 201662348620 P
10.06.2016 US 201662348416 P

(71) Applicant: Synlogic, Inc.
Cambridge, MA 02139 (US)

(72) Inventors:
  • FALB, Dean
    Sherborn, MA 01770 (US)
  • ISABELLA, Vincent, M.
    Cambridge, MA 02139 (US)
  • KOTULA, Jonathan, W.
    Somerville, MA 02143 (US)
  • MILLER, Paul, F.
    Salem, CT 06420 (US)
  • ROWE, Sarah
    Durham, NC 27707 (US)
  • MILLET, Yves
    Newton, MA 02460 (US)
  • FISHER, Adam
    Cambridge, MA 02139 (US)

(74) Representative: Murgitroyd & Company 
Scotland House 165-169 Scotland Street
Glasgow G5 8PL
Glasgow G5 8PL (GB)

   


(54) BACTERIA ENGINEERED TO TREAT METABOLIC DISEASES